878 related articles for article (PubMed ID: 24101529)
21. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
Youssef MA; Abou-Setta AM; Lam WS
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
[TBL] [Abstract][Full Text] [Related]
22. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
Zheng X; Guo W; Zeng L; Zheng D; Yang S; Xu Y; Wang L; Wang R; Mol BW; Li R; Qiao J
Hum Reprod; 2022 Jan; 37(2):242-253. PubMed ID: 34849920
[TBL] [Abstract][Full Text] [Related]
23. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
[TBL] [Abstract][Full Text] [Related]
24. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
25. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
26. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
[TBL] [Abstract][Full Text] [Related]
27. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
Franik S; Kremer JA; Nelen WL; Farquhar C
Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
[TBL] [Abstract][Full Text] [Related]
28. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.
McDonnell R; Marjoribanks J; Hart RJ
Cochrane Database Syst Rev; 2014; 2014(12):CD005999. PubMed ID: 25502626
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
31. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
Youssef MA; Mourad S
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
[TBL] [Abstract][Full Text] [Related]
32. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
[TBL] [Abstract][Full Text] [Related]
33. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
34. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
35. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
Walls M; Junk S; Ryan JP; Hart R
Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
[TBL] [Abstract][Full Text] [Related]
36. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
Gibreel A; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
[TBL] [Abstract][Full Text] [Related]
37. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF).
Pandian Z; McTavish AR; Aucott L; Hamilton MP; Bhattacharya S
Cochrane Database Syst Rev; 2010 Jan; (1):CD004379. PubMed ID: 20091563
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.
Farquhar C; Brown J; Marjoribanks J
Cochrane Database Syst Rev; 2012 Jun; (6):CD001122. PubMed ID: 22696324
[TBL] [Abstract][Full Text] [Related]
39. [Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols].
Wang P; Zhao J; Jin C; Yu R; Lin J; Zhu R; Wu Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):903-8. PubMed ID: 25608990
[TBL] [Abstract][Full Text] [Related]
40. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
